Cerebral MRI During Sleep

Sleep Clinical Trial

Official title:

Cerebral MRI During Sleep

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03304652
• Other study ID #: 170804
• Status: Completed
• Start date: October 1, 2017
• Est. completion date: October 31, 2018

Study information

• Verified date: March 2019
• Source: University of California, San Diego
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Recent studies in animal models have suggested a critical role for cerebrospinal fluid and Interstitial fluid flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. This effect is modulated during sleep, suggesting a potentially important mechanism for sleep to maintain both acute homeostasis and long-term cerebral health.

The central goal of these studies is to develop a sensitive MRI biomarker of cerebral conformational changes during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation.

Description:

Recent studies in animal models have suggested a critical role for cerebrospinal fluid (CSF) / Interstitial fluid (ISF) flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. It remains unknown to what extent these phenomena exist in the human brain. A key challenge in this work is to make non-invasive and reproducible measurements of the cerebral microenvironment in humans. For these studies, the investigators have implemented a suite of MRI measurements to track physiological changes in the brain during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation. The long term goal of this work is to use MRI as an imaging biomarker to assess the cerebral response to normal versus disordered sleep in patients.

Our specific aims will address the following questions:

Aim 1: How sensitive are MRI metrics for determining changes in the brain during sleep?

Aim 2: How reproducible are MRI metrics during sleep and during sedation?

The investigators will recruit 12 normal adult subjects for this study (consecutive respondees to recruitment adverts). The investigators will make regional MRI measurements during onset, maintenance and waking from stage N2 sleep. From these the investigators will characterize which MRI metrics are most sensitive to changes in the cerebral environment, and how these vary for different cerebral regions.

Measurements will be repeated during ~90 minutes of natural sleep, and following oral sedation with 10 mg zaleplon (Sonata).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11
• Est. completion date: October 31, 2018
• Est. primary completion date: October 31, 2018
• Gender: All
• Age group: 18 Years to 59 Years

Eligibility

Inclusion Criteria:

• Healthy Adults

Exclusion Criteria:

1. age not in range 18-59

2. smoking / recreational drug use

3. pregnant women / breast feeding

4. contraindication to MRI

5. contraindications to Zaleplon

6. history of cardiovascular pulmonary or cerebral disease (hypertension (diastolic >90 mmHg, systolic > 150 mmHg), unstable cerebrovascular syndromes, prior history of cardiac arrhythmias, unstable angina, chronic obstructive pulmonary disease).

7. Current SSRI antidepressant medication

8. History of sleep disorder or currently taking sedative / stimulant medication

Related Conditions & MeSH terms

• Sleep

Intervention

Drug:
• Zaleplon
Sleep Aid; 10mg; Oral; Single Use

Other:
• Natural Sleep
Natural Sleep without medication

Locations

Country	Name	City	State
United States	UC San Diego	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cerebral MRI Changes	Change in MRI Signal from Awake Baseline	90 Minutes of Sleep